Friedl-Naderer Johanna

Sociétés où Friedl-Naderer Johanna a négocié

• Dyne Therapeutics, Inc.15 tx · $29.5K · Jun 17, 2026
• Vir Biotechnology, Inc.5 tx · $33.8K · Mar 7, 2023

Historique de performance de Friedl-Naderer Johanna

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de Friedl-Naderer Johanna

Co-initiés de Friedl-Naderer Johanna

• Abu Dhabi Investment AuthorityVir Biotechnology, Inc.
• Alaska Permanent Fund CorpVir Biotechnology, Inc.
• ARCH Venture Fund IX, L.P.Vir Biotechnology, Inc.
• ARCH Venture Partners IX, LLCVir Biotechnology, Inc.
• ARCH Venture Partners IX, L.P.Vir Biotechnology, Inc.
• ARCH Venture Partners IX Overage, L.P.Vir Biotechnology, Inc.
• Atlas Venture Associates Opportunity II, LPDyne Therapeutics, Inc.
• Atlas Venture Associates Opportunity I, LLCDyne Therapeutics, Inc.
• Atlas Venture Associates XI, LLCDyne Therapeutics, Inc.
• Atlas Venture Associates XI, L.P.Dyne Therapeutics, Inc.
• Atlas Venture Fund XI, L.P.Dyne Therapeutics, Inc.
• Atlas Venture Opportunity Fund II, L.P.Dyne Therapeutics, Inc.
• Beskrovnaya OxanaDyne Therapeutics, Inc.
• Bill & Melinda Gates FoundationVir Biotechnology, Inc.
• BISCHOFBERGER NORBERT WVir Biotechnology, Inc.
• Brumm Joshua TDyne Therapeutics, Inc.
• Burow KristinaVir Biotechnology, Inc.
• BYBEE CLINTONVir Biotechnology, Inc.
• Coughlin Timothy PVir Biotechnology, Inc.
• COX JOHNDyne Therapeutics, Inc.
• CRANDELL KEITHVir Biotechnology, Inc.
• CureDuchenne Ventures, LLCDyne Therapeutics, Inc.
• De Backer MarianneVir Biotechnology, Inc.
• de Verneuil VaninaVir Biotechnology, Inc.
• Eisner MarkVir Biotechnology, Inc.